COMMUNIQUÉS West-GlobeNewswire

Sionna Therapeutics to Participate in Upcoming December Investor Conferences
24/11/2025
WALTHAM, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Sionna Therapeutics, Inc. (Nasdaq: SION), a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF [...]
Biomea Fusion to Participate at Upcoming Investor Conferences
24/11/2025
SAN CARLOS, Calif., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that it will [...]
Kymera Therapeutics to Participate in Upcoming December Investor Conferences
24/11/2025
WATERTOWN, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological [...]
Vaxil Announces Update on Non-Brokered Private Placement
24/11/2025
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Nov. 24, 2025 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (" Vaxil " or the " Company ") (TSX VENTURE: VXL) is pleased to announce that the Company, [...]
Ocular Therapeutix™ Announces First Patient Randomized in HELIOS-3 Phase 3 Registrational Program for AXPAXLI™ in NPDR
24/11/2025
First patient randomized into HELIOS-3, which along with HELIOS-2 form the basis of AXPAXLI’s registrational program in non-proliferative diabetic retinopathy (NPDR) HELIOS-2 and HELIOS-3 are global, complementary [...]
Seres Therapeutics to Participate in Piper Sandler Healthcare Conference
24/11/2025
CAMBRIDGE, Mass., Nov. 24, 2025 (GLOBE NEWSWIRE) -- Seres Therapeutics, Inc. (Nasdaq: MCRB), a leading live biotherapeutics company, today announced that management will participate in a fireside chat at the Piper [...]
Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
24/11/2025
Record Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million 1 , net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million 1 [...]
Cannara Biotech réalise des revenus et une rentabilité records pour l’exercice 2025 et affiche pour la première fois un solde positif de bénéfices non répartis
24/11/2025
R ésultats financiers records pour l'exercice 2025 : total des produits, déduction faite des taxes et de 107,3 millions de dollars, BAIIA ajusté de 28,1 millions de dollars 1 , bénéfice net de 13,1 millions de dollars, [...]
Pasithea Therapeutics Announces Completion of Cohort 7 in Ongoing Phase 1 Trial of PAS-004 in Advanced Cancer Patients, with Positive Safety, Pharmacokinetic (PK), and Pharmacodynamic (PD) Data
24/11/2025
-- Zero Treatment Related Adverse Events observed during Cohort 7 (37mg capsules) DLT period – --Cohort 7 Pharmacokinetic (PK) profile continues to demonstrate dose-proportionality and Cmax/Cmin ratio <2. Achieved [...]
Genmab to Participate in a Fireside Chat at the Citi Global Healthcare Conference in Miami
24/11/2025
Media Release COPENHAGEN, Denmark; November 24, 2025 Genmab A/S (Nasdaq: GMAB ) announced today that its C hief F inancial O fficer Anthony Pagano will participate in a fireside chat at the Citi Global Healthcare [...]
Boundless Bio to Participate in the Piper Sandler 37th Annual Healthcare Conference
24/11/2025
SAN DIEGO, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Boundless Bio , (Nasdaq: BOLD) a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with [...]
Managers’ transactions
24/11/2025
November 24, 2025 Announcement no. 28 Managers’ transactions In connection with the completion of BioPorto A/S’ directed issue as described in company announcement no. 27, BioPorto A/S has received notification pursuant [...]
BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes
24/11/2025
24 November 2025 Announcement no. 27 BioPorto A/S raises approximately DKK 43 million in new capital round - Change in number of shares and votes Completion of share capital increase COPENHAGEN, DENMARK, 24 November [...]
Genenta Reports Long-Term Survival Trends and Immune Findings in Brain Tumor (GBM) Trial
24/11/2025
Company Announces Approximately $30 Million in Cash and Short-Term Investments Following Its October 27th Registered Direct Offering MILAN, Italy and NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Genenta Science (Nasdaq: [...]
Rakovina Therapeutics Showcases Compelling Preclinical Data on AI-Discovered CNS-Penetrant ATR/mTOR Inhibitors at the 2025 Society for Neuro-Oncology Annual Meeting
24/11/2025
Variational AI’s Enki™ generative AI platform designed novel ATR/mTOR dual inhibitors with brain penetrance and activity in PTEN-deficient tumor models VANCOUVER, British Columbia, Nov. 24, 2025 (GLOBE NEWSWIRE) -- [...]
DXS INTERNATIONAL PLC (AQSE: DXSP): Notice of 2025 Annual General Meeting
24/11/2025
Monday 24 November DXS INTERNATIONAL PLC (AQSE: DXSP) Notice of 2025 Annual General Meeting The Board of DXS International plc (“the Company” or “DXSP”), the AQSE Growth Market quoted healthcare information and digital [...]
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
24/11/2025
EINDHOVEN, the Netherlands, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD – US ADR: ONWRY), the leading neurotechnology company pioneering therapies to restore movement, function, and [...]
Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key developments for its North American business
24/11/2025
Regulated information - inside information Nazareth (Belgium)/Rotterdam (The Netherlands), 24 November 2025 – 7:00 AM CET Fagron strengthens EMEA leadership with acquisitions in Poland and Hungary and announces key [...]
Sequana Medical Announces First U.S. Commercial alfapump® Implantation at Mount Sinai Hospital in New York
24/11/2025
Ghent, Belgium, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Milestone in bringing breakthrough treatment option to US patients with recurrent and refractory ascites due to liver cirrhosis Feedback from hepatology community [...]

Pages